Recruiting NCT06972225

NCT06972225 Restrospective Analysis of MACE in Patients Treated With Drug-elluting Balloons.

◆ AI Clinical Summary

Plain-language summary for patients

Clinical Trial Summary
NCT ID	NCT06972225
Status	Recruiting
Phase	—
Sponsor	Olivier F. Bertrand
Condition	Coronary Arterial Disease (CAD)
Study Type	OBSERVATIONAL
Enrollment	1,500 participants
Start Date	2025-06-10
Primary Completion	2035-12

Trial Parameters

Condition Coronary Arterial Disease (CAD)

Sponsor Olivier F. Bertrand

Study Type OBSERVATIONAL

Phase N/A

Enrollment 1,500

Sex ALL

Min Age 18 Years

Max Age N/A

Start Date 2025-06-10

Completion 2035-12

All Conditions

Coronary Arterial Disease (CAD) Restenosis, Coronary Bifurcation Coronary Disease

Interventions

DEB

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Your Age

Your Sex

Brief Summary

Retrospective analysis of data collected in an institutional database of coronary interventions with use of drug-eluting balloons, with a prospective follow-up for major adverse cardiovascular events and living status.

Eligibility Criteria

Inclusion Criteria: * Adults (\>=18 years of age) * Who underwent a coronary angioplasty with drug-eluting balloon between January 2010 and December 2025 * Identified in the institutional procedure database Exclusion Criteria: * Incomplete or non-available data on the post-procedural clinical follow-up * Procedures where other devices were used in combination with drug-eluting balloons.

Related Trials

NCT06822712

Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for De Novo Coronary Bi

View Trial →

NCT07068776

Shockwave Intervention for Enhanced Wound Healing in No-touch Pedicle Saphenous Vein Graft Harvestin

View Trial →

NCT06972225

Restrospective Analysis of MACE in Patients Treated With Drug-elluting Balloons.

View Trial →

VIEW ON CLINICALTRIALS.GOV ↗ MORE CORONARY ARTERIAL DISEASE (CAD) TRIALS

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology